openPR Logo
Press release

Anti-Asthmatics And COPD Drugs Market Share And Assessment | Forecast Analysis Report 2020-30: Covid 19 Impact And Recovery

08-18-2020 12:32 PM CET | Health & Medicine

Press release from: The Business research company

Anti-Asthmatics And COPD Drugs Market Share And Assessment |

Anti-Asthmatics And COPD Drugs Market By Type Of Therapy (Preventive, Curative) By Drug Class, By Distribution Channel, By End-Users And By Region – Global Forecast To 2023 By The Business Research Company

The global anti-asthmatics and COPD drugs market reached a value of nearly $40,162.1 million in 2019, having grown at a compound annual growth rate (CAGR) of 4.4% since 2015, and is expected to grow at a CAGR of 4.1% to nearly $47,176.2 million by 2023. Also the market is expected to growth to $51,164.1 million in 2025 at a CAGR of 4.1% and to $63,579.9 million in 2030 at a CAGR of 4.4%.

The Key drivers of the anti-asthmatics and COPD drugs market include:
Increased Incidence Of Tobacco Smoking – The increased use of tobacco led to a rise in tobacco related respiratory diseases such as COPD which in turn drove the anti-asthmatic and COPD drugs market during the historic period. While the global rate of smoking reduced, the increase in the population led to an increased number of smokers.

Browse Complete Report @
https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Anti-Asthmatics And COPD Drugs Market Segmentation:
The anti-asthmatics and COPD drugs market is segmented by type of drug class, by end-user, by distribution channel, by therapy and by geography

By Type Of Drug Class - The anti-asthmatics and COPD drugs market can be segmented by type of drug class into
1) Combination Drugs
2) Bronchodilators
3) Monoclonal Antibodies
4) Anti-Inflammatory Drugs
The combination drugs market was the largest segment of the anti-asthmatics and COPD drugs market by drug class, accounting for $14,964.9 million or 37.3% of the total market in 2019. The monoclonal antibodies market is expected to be the fastest-growing segment going forward at a CAGR of 7.4%

By End-Users – The anti-asthmatics and COPD drugs market is segmented by end-user into
1) Asthma Patients
2) COPD Patients

By Distribution Channel - The anti-asthmatics and COPD drugs market can be segmented by distribution channel into
1) General Pharmacies
2) Hospital Pharmacies
3) Online Retailers

By Type Of Therapy - The anti-asthmatics and COPD drugs market can be segmented by type of therapy into
1) Preventive
2) Curative

Request For A Sample Copy Of Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=2417&type=smp

By Geography - The anti-asthmatics and COPD drugs market is segmented by geography into
1. North America
2. Western Europe
3. Asia Pacific
4. Eastern Europe
5. South America
6. Middle East
7. Africa

Some of the major key players involved in the anti-asthmatics and COPD drugs market are
1. GlaxoSmithKline plc
2. AstraZeneca plc
3. Boehringer Ingelheim GmbH
4. F. Hoffmann-La Roche Ltd.
5. Novartis AG

Place a DIRECT PURCHASE ORDER of report @
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2417

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-Asthmatics And COPD Drugs Market Share And Assessment | Forecast Analysis Report 2020-30: Covid 19 Impact And Recovery here

News-ID: 2115344 • Views:

More Releases from The Business research company

Fertilizing and Plant Protection Equipment Market to Grow to $97.81 Billion by 2028 within Forecast period 2024-2033, Fueled by Global Food Demand
Fertilizing and Plant Protection Equipment Market to Grow to $97.81 Billion by 2 …
The fertilizing and plant protection equipment market size has grown strongly in recent years. It will grow from $71.76 billion in 2023 to $76.79 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to rise in commercial farming, government subsidies and policies, environmental concerns, precision agriculture adoption, chemical pesticide regulation. The fertilizing and plant protection equipment market size is
Explosive Ordnance Disposal Equipment Market to Grow to $7.31 Billion by 2028 over Forecast Period 2024-2033, Fueled by Technological Advancements
Explosive Ordnance Disposal Equipment Market to Grow to $7.31 Billion by 2028 ov …
The explosive ordnance disposal equipment market size has grown steadily in recent years. It will grow from $5.85 billion in 2023 to $6.13 billion in 2024 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to global security concerns, increasing ied threats, homeland security initiatives, humanitarian mine clearance, military modernization programs, improvements in training programs. The explosive ordnance disposal equipment market size
Electronic Drug Delivery Systems Market to Grow to $16.12 Billion by 2028, Driven by Personalized Medicine: Key Players Include Gerresheimer AG and Amgen Inc.
Electronic Drug Delivery Systems Market to Grow to $16.12 Billion by 2028, Drive …
The electronic drug delivery systems market size has grown strongly in recent years. It will grow from $10.54 billion in 2023 to $11.45 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to risen chronic diseases incidence, aging population, patient preference for non-invasive delivery, healthcare cost containment, clinical advancements and validation. The electronic drug delivery systems market size is
Rising Meat and Milk Consumption Drives Growth in Direct-Fed Microbials (DFM) Market, Meets Growing Demand
Rising Meat and Milk Consumption Drives Growth in Direct-Fed Microbials (DFM) Ma …
The direct-fed microbials (dfm) market size has grown strongly in recent years. It will grow from $1.25 billion in 2023 to $1.35 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to shift towards natural feed additives, performance improvement in livestock, regulatory support for animal health, increased focus on gut health, consumer demand for antibiotic-free products. The direct-fed microbials

All 5 Releases


More Releases for COPD

Copd CBD Gummies: Reviews (Shocking Facts) Copd CBD Oil "Ingredients" Pain Relie …
Copd CBD Gummies: With the increasing need for both individual and expert degrees, the stress and also stress are also enhancing. Individuals are using various methods to fight it. However, as a result of much less time for self, it is really hard. Here the natural herbs and supplements have actually discovered their way into our lives. The Copd CBD Oil are instances of super-effective natural supplements. The CBD existing
Power Harmonica to Cure Chronic Asthma & COPD
Power Harmonica is a free reed wind musical instrument. It is small rectangular shaped musical instrument. It has 48 number of holes which makes it special and different from other harmonica's. It's a pocket-friendly musical instrument. Power Harmonica is used as a natural treatment for many types of lung disorders and has no side effects. To play Power Harmonica there is no need of having a musical background it can be
COPD Therapeutics Global Market Research Report 2019
COPD Therapeutics Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/copd-therapeutics-market/80858 The report firstly introduced the COPD Therapeutics basics: definitions, classifications, applications and market
Global COPD and Asthma Devices Market Size
According to a new report, Global COPD and Asthma Devices Market, published by KBV Research, The Global COPD and Asthma Devices Market attained a market size of $ 27,465.1 Million in 2015 and is expected to reach $ 39,051.4 Million by 2022 growing at a CAGR of 5.2 % CAGR during 2016 – 2022. The Asia Pacific market dominated the Global COPD and Asthma Devices Market in 2015 and would
COPD Drug Market Opportunity & Clinical Pipeline Analysis
Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the
04-10-2017 | Health & Medicine
TMR
Asthma and COPD Drugs Market: High Costs of Asthma and COPD Drugs and Consumer A …
Asthma is a disease characterized by recurrent attacks of coughing, chest-tightening, breathlessness, and wheezing as the airways narrow and swell that vary in severity and frequency. COPD is a disease of the lungs characterized by obstruction to airflow that interferes with normal breathing. According to the WHO, COPD accounted for over 3 million deaths in 2012, which is equal to 6% of all deaths globally in that year. Moreover, the